Skip to Content

Sernova Corp SEOVF

Morningstar Rating
$0.33 0.00 (0.43%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

SEOVF is trading at a 57% discount.
Price
$0.33
Fair Value
$2.13
Uncertainty
Extreme
1-Star Price
$15.80
5-Star Price
$6.67
Economic Moat
Hcgd
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if SEOVF is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$0.33
Day Range
$0.330.33
52-Week Range
$0.290.83
Bid/Ask
$0.28 / $0.42
Market Cap
$100.22 Mil
Volume/Avg
11,100 / 19,597

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Sernova Corp is a clinical-stage company developing products for the treatment of chronic debilitating diseases. The company is engaged in the research and development of its proprietary Cell Pouch and associated technologies including immune-protected therapeutic cells. The Cell Pouch is is a scalable, implantable medical device designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells, which then release proteins, hormones or other factors into the bloodstream for the long-term treatment of multiple chronic diseases such as type 1 diabetes, hypothyroid disease, and rare diseases such as hemophilia A.
Sector
Healthcare
Industry
Biotechnology
Stock Style Box
Small Value
Total Number of Employees
26

Comparables

Valuation

Metric
SEOVF
KROS
CBAY
Price/Earnings (Normalized)
Price/Book Value
35.035.3512.65
Price/Sales
111.01
Price/Cash Flow
Price/Earnings
SEOVF
KROS
CBAY

Financial Strength

Metric
SEOVF
KROS
CBAY
Quick Ratio
1.1713.6310.70
Current Ratio
1.2014.2510.96
Interest Coverage
−1,285.53−5.27
Quick Ratio
SEOVF
KROS
CBAY

Profitability

Metric
SEOVF
KROS
CBAY
Return on Assets (Normalized)
−115.56%−35.62%−30.06%
Return on Equity (Normalized)
−168.47%−39.15%−51.97%
Return on Invested Capital (Normalized)
−166.67%−41.95%−30.87%
Return on Assets
SEOVF
KROS
CBAY
See how this stock stacks up to its competitors with Morningstar Investor

Biotechnology Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
NVO
Novo Nordisk A/S ADRDnjbzghhDbwl$557.8 Bil
VRTX
Vertex Pharmaceuticals IncKmsxvtrSkvgz$103.3 Bil
REGN
Regeneron Pharmaceuticals IncZbfzdzpgZyrywc$98.8 Bil
MRNA
Moderna IncLwhcydshqLqsx$38.8 Bil
ARGX
argenx SE ADRFqwlkkphZwxd$21.3 Bil
BNTX
BioNTech SE ADRNflvjqgKqpt$20.8 Bil
ALNY
Alnylam Pharmaceuticals IncTbxdzbsJhxmhmt$18.4 Bil
BMRN
Biomarin Pharmaceutical IncFqrymhhDhwtfn$17.0 Bil
RPRX
Royalty Pharma PLC Class ALbmhhxcznNtbmpbn$12.4 Bil
INCY
Incyte CorpLvbbwclLkdrtp$11.9 Bil

Sponsor Center